Yield10 Bioscience Announces First Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/31/2026
- Take-Two stock drops as GTA 6 leaks continue
- GameStop posts higher income despite revenue drop in Q2 2026
- At least eight die, 18 missing after ferry capsizes off North Cyprus
- Goldman Sachs raises humanoid robot forecast, sees auto role
- PG&E downgraded by Wells Fargo, BMO as California wildfire reform falls short
Yield10 Bioscience, Inc. (YTEN) Misses Q1 EPS by 15c
May 14, 2020 4:28 PM EDTYield10 Bioscience, Inc. (NASDAQ: YTEN) reported Q1 EPS of ($2.12), $0.15 worse than the analyst estimate of ($1.97). Revenue for the quarter came in at $179 thousand versus the consensus estimate of $170 thousand.
Recent Accomplishments in 2020
Appointed Sherri M. Brown, Ph.D., to the Board of Directors. Dr. Brown will also serve as the chair of the newly formed Science and Technology Committee of the Board.Secured a positive response from USDA-APHIS on the regulatory status of our CRISPR genome-edited C3007 trait in Camelina, paving the way for U.S. field tests in... More